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Introduction: Identification of participants at clinical high-
risk (CHR) for the development of psychosis is an impor-
tant objective of current preventive efforts in mental health 
research. However, the utility of using web-based screen-
ing approaches to detect CHR participants at the popula-
tion level has not been investigated. Methods: We tested a 
web-based screening approach to identify CHR individuals. 
Potential participants were invited to a website via e-mail 
invitations, flyers, and invitation letters involving both the 
general population and mental health services. Two thou-
sand two hundred seventy-nine participants completed the 
16-item version of the prodromal questionnaire (PQ-16) 
and a 9-item questionnaire of perceptual and cognitive 
aberrations (PCA) for the assessment of basic symptoms 
(BS) online. 52.3% of participants met a priori cut-off cri-
teria for the PQ and 73.6% for PCA items online. One 
thousand seven hundred eighty-seven participants were 
invited for a clinical interview and n = 356 interviews were 
conducted (response rate: 19.9%) using the Comprehensive 
Assessment of At-Risk Mental State (CAARMS) and the 
Schizophrenia Proneness Interview, Adult Version (SPI-
A). n = 101 CHR participants and n = 8 first-episode psy-
chosis (FEP) were detected. ROC curve analysis revealed 
good to moderate sensitivity and specificity for predicting 
CHR status based on online results for both UHR and 
BS criteria (sensitivity/specificity: PQ-16  =  82%/46%; 
PCA = 94%/12%). Selection of a subset of 10 items from 
both PQ-16 and PCA lead to an improved of specificity 
of 57% while only marginally affecting sensitivity (81%). 
CHR participants were characterized by similar levels of 
functioning and neurocognitive deficits as clinically iden-
tified CHR groups. Conclusion: These data provide ev-
idence for the possibility to identify CHR participants 
through population-based web screening. This could be an 
important strategy for early intervention and diagnosis of 
psychotic disorders.
Key words:  clinical high-risk/psychosis/early 
intervention/web screening/basic symptoms
Background
The identification of young people at high-risk for the 
development of severe mental health disorders is an im-
portant objective in current research and clinical prac-
tice.1–4 Over the last 3 decades, clinical criteria have been 
developed that allow the identification of participants 
with a high-risk of developing psychotic disorders, such 
as schizophrenia (ScZ).5,6 These include ultra high-risk 
(UHR) criteria that involve the presence of attenuated, 
psychotic symptoms as assessed by the Comprehensive 
Assessment of At-Risk Mental State (CAARMS) instru-
ment6 or through the Structured Interview for Psychosis-
Risk Syndromes (SIPS).7 Moreover, UHR criteria 
instruments include a genetic risk plus functional dete-
rioration syndrome as well as brief  limited intermittent 
psychotic episodes (BLIPs). In parallel, clinical high-
risk (CHR) criteria also have been based on the basic 
symptom (BS) concept8 that are based on the presence of 
self-experienced perceptual and cognitive anomalies that 
are thought to represent the earliest manifestation of psy-
chosis risk.8
There is now consistent evidence that these instruments 
allow a reliable identification of CHR participants9 with 
transition rates ranging between 10% and 50% over a 2- 
to 5-year period.10 Interestingly, recent studies have shown 
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that the combined presence of both BS and UHR criteria 
increases the predictive power significantly.11 The impor-
tance of detecting CHR individuals is also underlined by 
the fact that at-risk populations show high correlations with 
nonpsychotic symptoms12 and mental health outcomes in 
those cases that do not develop psychotic disorders meet 
criteria for a range of other diagnoses, including affective 
disorders, personality disorders, and substance abuse.13,14
A major limitation for current approaches to detect 
CHR participants is the fact that CHR criteria need 
to be established through semi-structured interviews 
administered by trained personnel in help-seeking pop-
ulations who are already within the health care system. 
Accordingly, it would be important to develop novel ways 
of identifying CHR participants that could potentially 
circumvent clinical entry points and allow population-
wide screening of potential signs of impending psychosis 
and related mental disorders.
E-mental health applications, such as online screen-
ing for emerging mental health conditions, could provide 
an important approach to target young people at-risk for 
psychosis as they could facilitate identifying potential par-
ticipants who would benefit from more detailed psychi-
atric assessments. To investigate this possibility, the Youth 
Mental Health Risk and Resilience Study (YouR Study) 
implemented a website http://www.your-study.org.uk which 
includes an initial screening through the 16-item version of 
the prodromal questionnaire (PQ-16)15 and a 9-item scale 
of perceptual and cognitive aberrations (PCA). Previous 
studies using questionnaire-based screenings in mental 
health settings and the general population highlighted the 
potential utility of using screening tools to identify CHR 
individuals.16–18 For example, the PQ-16 produced correct 
classification of UHR individuals in a secondary mental 
health setting with high sensitivity and specificity.15
Accordingly, we tried to determine whether question-
naire-based assessments of both attenuated psychotic 
experiences and BS through an online platform are char-
acterized by sufficient sensitivity and specificity to predict 
CHR status as determined by clinical interviews. A sec-
ondary objective was to characterize the neurocognitive 
and psychopathological characteristics of CHR partici-
pants recruited through an online approach and compare 
results with at-risk samples in previous studies that were 
identified through clinical pathways.
Specifically, we predicted that self-reported levels of 
attenuated psychotic experiences and BS obtained on-
line would predict CHR criteria as assessed through 
the CAARMS and SPI-A interviews. In addition, CHR 
participants identified through online screening were ex-
pected to be characterized by similar levels of functioning 
and neurocognitive deficits as clinically identified CHR 
individuals, suggesting that E-mental health applica-
tions may be effective in the detection of early signs of 
psychosis in the general population and in help-seeking 
participants.
Methods
Recruitment and Participants
The YouR Study is a cross-sectional study to identify 
neurobiological mechanisms and predictors of psychosis-
risk with a state-of-the-art neuroimaging approach (mag-
netoencephalography, magnetic resonance spectroscopy, 
magnetic resonance imaging) in combination with core 
psychological processes, such as affect regulation, adverse 
experiences, and attachment.19 The YouR study is funded 
by the Medical Research Council (MRC).
A website was implemented http://www.your-study.
org.uk as part of the study protocol and potential par-
ticipants were invited through e-mail invitations, flyers, 
advertisements, and general practioners  (GP) letters. 
Specifically, email invitations were sent out to colleges 
and Universities in Glasgow and Edinburgh. In addi-
tion, posters and flyers were advertised in NHS clin-
ics and public transportation. Finally, databases of GP 
practices were searched for potential participants who 
then received an invitation letter that directed them to the 
website.
The study was approved by the ethical committees 
of the NHS Research Ethical Committee Glasgow & 
Greater Clyde.
Informed consent for the web screening was provided 
online, followed by 2 questionnaires: (a) the PQ-1615 and 
(b) a 9-item PCA scale that was developed to assess BS 
(Appendix). The PQ-16 was developed by Ising et  al.15 
from the 92-item prodromal questionnaire (PQ)20 in 
a help-seeking population attending secondary men-
tal health services. A  cut-off  score of 6 or more items 
was associated with UHR criteria as assessed by the 
CAARMS with high sensitivity (87%) and specificity 
(87%). Items for the PCA were generated from existing 
patient descriptions of cognitive and perceptual experi-
ences21 and from the SPI-A.22 Participants were asked to 
provide ratings based on experience in the last 12 months.
Cut-off  criteria for further clinical assessments were 6 
or more positively endorsed items on the PQ-16 based on 
previous data suggesting correct classification of CHR 
criteria based on CAARMS interviews with high sensi-
tivity and specificity.15 For the PCA, a cut-off  score of 3 
or more positively endorsed items was selected.
Clinical Assessments and CHR Criteria
Participants who met online inclusion criteria (PQ: ≥6 
items; PCA: ≥3 items) were invited through an email 
to participate in the second part of  the study that in-
volved clinical assessments to determine CHR status 
and neuropsychology assessments (figure  1). At the 
beginning of  the appointment, informed consent was 
obtained and the positive scale of  the CAARMS6 
and items of  the Schizophrenia Proneness Instrument 
(SPI-A)22 to determine at-risk criteria as defined by 
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cognitive-perceptive basic symptoms (COPER) and 
cognitive disturbances (COGDIS) were administered 
through trained research assistants and MSc/PhD level 
researchers. CHR participants were excluded for cur-
rent or past diagnosis with Axis I psychotic disorders. 
Other co-morbid Axis I  diagnoses, such as mood or 
anxiety disorders, were not exclusionary and all partici-
pants were between 16 and 35 years of  age (for more 
details, see Uhlhaas et al19).
A second appointment served to verify CAARMS 
and SPI-A items and the M.I.N.I. International 
Neuropsychiatric Interview (M.I.N.I. 6.0).19 Moreover, 
the scales for premorbid adjustment,23 social and func-
tional role scales24 and the Brief  Assessment of Cognition 
in Schizophrenia Battery (BACS) were administered.25 
Participants were recruited into the CHR group if  they 
meet (a) SPI-A COGDIS/COPER criteria, (b) ARMS 
attenuated psychosis group (subthreshold psychotic syn-
drome present in the last year without a decline in func-
tioning), (c) ARMS vulnerability group (family history of 
psychosis plus a 30% drop in the Global Assessment of 
Functioning [GAF] scale), and (d) ARMS BLIPs group 
(brief  limited intermittent psychotic symptoms).
Statistical Analyses
Data were analyzed using SPSS version 18.0.
ROC Analyses
To investigate the sensitivity and specificity of online screen-
ing scores toward predicting CHR status, we conducted 
ROC analyses. Pairwise comparison of ROC curves was 
performed to test the statistical significance of the differ-
ence between the areas under the ROC curves of the PQ-16 
and the PCA. The accuracy of the test depends on how well 
the test separates the group being tested into those with 
and without the disorder in question and is measured by 
the area under the curve (AUC). An AUC test value equal 
to 0.5 means that there is no difference and when the value 
equals 1 there is perfect separation of the values of the 2 
groups.
Results
Screening Results
A total of n  =  2296 participants completed the online 
screening from the commencement of the study in 
Fig. 1. Recruitment and screening pathway. 
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September 2014 until July 2017. 52.3% participants 
(n = 1202) fulfilled the PQ-16 cut-off  criteria (≥6 or more 
items) while 73.6% (n = 1691) met criteria for the PCA 
(≥3 or more items). Participants were invited for inter-
views until July 2017 and 356 interviews were conducted 
(a response rate of 19.9%). There were no significant 
differences between participants who accepted invita-
tions for interviews vs those who did not on the PQ-16 
[t(1785)  =  0.63, P  =  .53]. A  statistical trend emerged 
for higher scores on the PCA scale for participants who 
attended clinical assessments [t(1785) = 1.81, P = .07].
Sample Characteristics
CAARMS/SPI-A interviews were conducted and n = 101 
participants met CHR criteria and n  =  8 first-episode 
(FEP) criteria (mean age: 21.8  years; gender: 6 male; 
years of education: 13.67 years, ScZ: n = 3, schizoaffec-
tive disorder: 2: psychotic disorder not otherwise speci-
fied (NOS): 1, bipolar disorder with psychotic features: 
1). FEP was defined as a person who fulfilled DSM-V 
for psychotic disorders that had previously not been in 
contact with mental health services. N = 215 were below 
CHR criteria (CHR negative group). For n  =  32 par-
ticipants, there was insufficient data to determine CHR 
status due to withdrawal from the interview and/or the 
tattoos/piercings that were exclusion criteria of the neu-
roimaging protocol. These participants were excluded 
from subsequent analysis. For 14 CHR participants, 
neuropsychological data were not available. Of the 101 
CHR participants, n = 87 were recruited from the general 
population (e-mail invitations, flyers, and posters) while 
14 were recruited through the National Health Service 
(NHS) (GP letters, posters).
In addition, we carried out SPI-A and CAAMRs inter-
views in n  =  27 participants who scored below online 
cut-offs for PQ and PC-Q items (online validation sam-
ple, OVS). Two out of 27 participants met CHR crite-
ria. However, there was a significant delay between the 
initial online score and clinical assessments, suggest-
ing that CHR symptoms emerged after the entry of 
questionnaire data.
Demographic and clinical characteristics of CHR par-
ticipants, CHR negative, OVS, and control groups as well 
as a sample of matched control participants are summa-
rized in table 1. Fourteen CHR participants were in cur-
rent treatment for mental health problems (NHS services: 
n = 8; other services (student counseling, charities): n = 7). 
Thirty-one CHR participants disclosed no previous or 
current contact with mental health services while 55 had 
previous contact (n = 16 NHS, n = 13 other services). For 
10 CHR participants, no information was available.
Table 1. Demographical and Clinical Characteristics of Participants
CHR Group 
(N = 101)
CHR Negative 
(N = 215) OVS (N = 27) Controls (N = 38) Statisticsa
Mean age (y) 22.03 (4.0) 22.71 (4.6) 19.81 (2.1) 23.07 .05 (CHR vs OVS)
Gender (male/female) 24/77 69/146 5/22 16/26 .05 (CHR vs OVS)
Education (y) 15.74 (2.9) 15.74 (3.1) 14.56 (2.3) 16.63 (2.8) .05 (CT vs OVS)
CHR category
 SPI-A  71
 CAARMS  73
 SPI-A/CAARMS  43
BACS datab
 Verbal memory 50.84 (11.0) 50.42 (8.9) .83
 Digit sequencing 20.72 (4.0) 20.66 (2.7) .93
 Token motor task 67.83 (14.1) 79.03 (12.9) .01
 Verbal fluency 57.06 (13.9) 59.45 (14.6) .39
 Symbol coding 67.78 (13.3) 74.42 (9.8) .05
 Tower of London 18.21 (2.4) 18.37 (1.9) .72
 Total score 283.34 (36.0) 302.34 (25.9) .05
GAF 61.06 (12.1) 75.32 (11.3) 76.75 (8.3) 88.68 (5.3) .00 (CT vs CHR+, CT vs CHR−, 
CT vs OVS, OVS vs CHR+, OVS 
vs CHR−, CHR vs CHR+
Role/social functioning
 Role current 7.60 (1.1) 8.63 (0.7) .01
 Social current 7.77 (0.9) 8.89 (0.4) .01
Premorbid adjustment
Childhood 1.02 (0.9) 0.36 (0.6) .01
 Early adolescence 1.13 (0.8) 0.49 (0.6) .01
 Late adolescence 1.04 (0.7) 0.69 (0.9) .01
aAll statistical comparisons were carried out with a one-way ANOVA except for differences in gender where a chi-squared test was 
applied. Standard deviations are in brackets where appropriate.
bBACS data was only available from n = 87 CHR participants.
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CHR participants were characterized by a significant 
lower GAF score compared with CHR negative partici-
pants. The OVS group was significantly younger than 
CHR negative participants and had fewer male partici-
pants and had less years of education.
Compared with controls, the CHR group was charac-
terized by reduced role and social functioning as well as 
impaired premorbid adjustment. The large majority of 
CHR participants met  also criteria for Axis-1 affective 
and anxiety disorders (table 2). Comparisons on neuro-
psychological measures revealed that CHR participants 
showed significant deficits in motor speed, symbol cod-
ing, and in the BACS composite score compared with 
controls (table 1).
Internal Consistency of PCA
Cronbach’s alpha was measured to assess the internal 
consistency of the PCA questionnaire. The total score 
on PCA was associated with a value of 0.786, suggesting 
that the items have high internal consistency.
ROC Analyses
ROC curves were plotted and AUC calculated to assess 
the predictive value of online PQ-16 and PCA scores in 
relationship to CHR status for interviewed participants 
that included n = 27 participants that did not meet online 
cut-off  criteria (total sample: n = 351) (table 3, figure 2).
The AUC for the PQ-16 for predicting CAAMRS sta-
tus was significant indicating that total symptom endorse-
ment score was predictive of CAARMS status above 
chance level. A cut-off  score of 6 or more symptom items 
on the PQ-16 was found to identify at-risk status with a 
sensitivity of 81% and specificity of 44%. Increasing the 
cut-off  score to 7 endorsed items decreased sensitivity to 
73% but increased specificity 55%.
The AUC for the PCA was also significant (figure 2). 
A  cut-off  score of 3 or more symptom items endorsed 
was found to identify SPI-A status with a sensitivity of 
95% and specificity of 13%. An alternative threshold of 4 
and 5 items or more symptom items endorsed improved 
specificity (4 items: sensitivity = 90%; specificity: 26%; 5 
items: sensitivity = 83%; specificity: 44%) (table 3).
To assess the utility of combining the subscales of the 
online questionnaire to predict CHR status further ROC 
analysis was conducted where the PQ-16 and PCA sub-
scales were combined (table 3, figure 2). The AUC was 
significant, indicating that symptom endorsement score 
across the subscales was predictive of CHR status. A cut-
off  score of 10 or more symptom items endorsed was 
found to identify CHR status with a sensitivity of 89% 
and specificity of 43%, thus slightly improving scores 
from the individual measures.
To examine the possibility to improve the specificity of 
the online screener, we implemented a machine-learning 
approach implemented in MATLAB 2015a: RELIEFF26 
which estimates the utility of features to a classification 
problem in the situation where features may have condi-
tional dependencies. For this analysis, we selected all 25 
items from both the PQ-16 and the PCA in addition to 3 
demographical variables: (a) age, (b) sex, and (c) familial 
risk (first degree relative with a psychotic disorder) that 
were obtained during the initial clinical assessment. We 
took the average predictive weights from 10 samples of 
234 individuals’ data set and ranked the features (sup-
plementary figure  1; table 4). The presence of a family 
Table 2. Clinical Characteristics of CHR+ Participants
Diagnosis
 Anxiety disorder 77.8%
 Mood disorder 61.1%
 Post-traumatic stress disorder 9.0%
 Eating disorder 13.8%
Learning disability
 a) Autism 1%
 b) ADHD 3%
 c) Dylexia 8%
Medication
 Anti-depressants 17.9%
 Anti-psychotics 0%
 Anxiolytics 0%
 Other 11%
Table 3. ROC-Analyses for PQ-16, PCA and PCA/PQ-16 Combined
Measure Cut-off Sensitivity Specificity PPV % NPV % LR+ AUC
Standard 
Error 95% CI P
PQ-16 6 0.81 0.44 29 89 1.45 0.72 0.033 0.66–0.78 <.001
PQ-16 7 0.73 0.55 32 88 1.62
PCA 3 0.95 0.13 25 89 1.06 0.69 0.033 0.62–0.75 <.001
PCA 4 0.90 0.26 27 90 1.22
PCA 5 0.83 0.44 31 89 1.48
Combined 10 0.89 0.43 42 89 1.56 0.74 0.028 0.69–0.80 <.001
Note: PPV is the positive predictive—true positive/(true positive + false positives); NPV is the negative predictive value—true negative/
(true negative + false negative). The NPV is very high for all these measures ie, a negative score really is likely to be negative. The PPV is 
relatively low (above threshold is 1/3 chance of being a genuine positive).
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member was ranked the seventh most predictive, while 
neither age, nor gender proved more useful than any 
of the questionnaire responses. We then recalculated 
the ROC curves, adding familial risk to the original 25 
features.
We then recomputed the ROC curve for increasing num-
bers of features, in sequence, adding one feature at a time, 
in order of predictive rank determined by RELIEFF. We 
then compared the specificity of solutions with the sensi-
tivity value closest to 80%. We found that a smaller num-
ber of items (10 or 12) that optimized the likelihood ratio 
(LR+) that included familial risk, improved specificity 
(57%), while only marginally affecting sensitivity (81%).
Discussion
The current study examined the possibility of detect-
ing CHR participants through a web-based screening 
approach that utilized the PQ-16 as well as a 9-item PCA 
scale in the general population and through clinical serv-
ices. Our data suggest that both screening instruments are 
characterized by good to moderate sensitivity and speci-
ficity to predict CHR status as defined by CAARMS and 
SPI-A interviews.
The PQ and abbreviated versions have been used in 
previous studies to detect CHR participants in secondary 
mental health settings.15,18,27 The online implementation 
of the PQ-16 in combination with a previously estab-
lished cut-off  6 or more items yielded similar sensitivity 
and specificity values to predict UHR status established 
through a semi-structured interview as in the study by 
Ising et al.15 Specifically, we observed that a score of 6 or 
more positively answered items was associated with UHR 
status as assessed by the CAARMS with good sensitivity 
(81%) and specificity (44%).
A novel approach of the current study was the imple-
mentation of a screening instrument to predict self-
experienced PCAs that are highly predictive for later 
transitioning to psychosis.5,11 Currently, it is unclear 
whether BS can be reliably predicted from self-report 
measures. The 9-item PCA was characterized by excellent 
sensitivity for predicting COPER and COGDIS status 
assessed through the SPI-A interview (95%) but low spec-
ificity (13%). Our data show that changing the cut-off  to 
4 or more items was associated with improved specificity.
The combination of a subset of features from the 
PQ-16 and PCA that included familial risk furthermore 
improved specificity (57%), highlighting the potential for 
improved online screening using a novel combination 
of features. However, we wish to note that this screener 
would require further validation in an independent 
sample.
An important issue concerns the clinical and demo-
graphic characteristics of CHR participants in the cur-
rent sample who are self-referred and identified through 
an online screening from the general population and 
clinical services. Overall, the majority of CHR partici-
pants were recruited from the general population and 
only a minority were in current or past treatment with 
NHS services. Our data indicate that the current sample 
shares similarities with existing CHR populations iden-
tified through clinical referral pathways. Specifically, the 
CHR participants identified through our web interface 
Fig. 2. Receiver operating characteristic (ROC) curves of 
predictive values for online questionnaires scores toward CHR 
status. Blue line: ROC curve for PQ-16 scores in relationship to 
UHR status as assessed by the CAARMS. Red line: ROC curve 
for PCA scores in relationship to SPI-A CHR status. Green line: 
ROC curve for combined PQ-16/PCA scores and CHR status. 
Black dashed line: reference line of performance no better than 
chance.
Table 4. ROC Analyses for a Subset of Questionnaire and Demographic Data
Number of 
Items Threshold Sensitivity Specificity PPV % NPV % LR+ AUC SE 95% CI P
12 5 0.80 0.57 46 86 1.86 0.73 0.028 0.67–0.78 <.001
11 4 0.84 0.51 45 77 1.71 0.72 0.03 0.65–0.77 <.001
10 4 0.81 0.57 54 77 1.88 0.71 0.028 0.65–0.76 <.001
Note: PPV is the positive predictive—true positive/(true positive+ false positives); NPV is the negative predictive value—true negative/
(true negative +false negative). The NPV is very high for all these measures, ie, a negative score really is likely to be negative. The PPV is 
relatively low (above threshold is 1/3 chance of being a genuine positive).
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are characterized by reduced GAF scores and impaired 
role and social functioning. However, especially role and 
social functioning was somewhat higher than in previous 
CHR samples.24,28
Consistent with previous data,29 we observed mild 
impairments in neurocognition in CHR participants 
compared with healthy controls. Specifically, reductions 
on the digit symbol and motor token task were observed 
that replicate findings highlighting the contribution of 
reductions in processing speed toward psychosis risk.30,31 
Interestingly, both verbal memory and executive func-
tions were found largely to be intact in the current CHR 
sample that is in contrast to deficits reported in previous 
studies.29,32,33
Baseline assessment of current psychopathology fur-
thermore revealed extensive psychiatric co-morbidity of 
CHR participants. In particular, both anxiety and mood 
disorders were present in the large majority of CHR 
participants consistent with previous formulations that 
that changes in affect are frequent early signs before the 
onset of psychosis.34 Together with the presence of PTSD 
and eating disorders in the current sample, these find-
ings support the view that CHR participants express a 
high degree of comorbidity with other psychiatric syn-
dromes12–14 which are likely to impact on the trajectory 
and functional outcome.35
Limitations and Further Steps
The current findings have a number of limitations. Firstly, 
we could only verify at-risk criteria established through 
online screening for UHR and BS symptoms in a sub-
group of individuals as only 19.9% of those participants 
who met online screening cut-offs were evaluated through 
CAARMS and SPI-A interviews. However, the current 
data suggest that there were no significant differences in 
scores on the PQ-16 and only a trend for difference PCA 
scores. Secondly, we could only establish in a small sam-
ple of n = 27 participants, the relationship between scores 
below the online cut-off  for CHR status and SPI-A as 
well as CAARMS criteria. Finally, since both PQ-16 and 
PCA measures were completed online, it is possible there 
was an overendorsement of PLE and BS (see de Jong 
et al36 for a recent study in adolescents). Moreover, it was 
not possible to determine how many of the target popu-
lation visited our website. However, we would like to note 
that the frequency of both PLEs as well as CHR crite-
ria were significantly less prevalent in our online sample 
compared to estimates obtained from the general popu-
lation,37,38 suggesting that the help-seeking participants 
were self-selecting with significantly higher levels of PLE 
as well as affective disorders.
In the current sample, ~1 out of 3 participants who 
met online cut-off  criteria was also found to either meet 
UHR or SPI-A status, suggesting that population wide-
screening may be useful in the detection of emerging 
signs of psychosis and related mental health outcomes. 
In addition, we also would like to note that the current 
recruitment approach identified a significant number of 
participants meeting criteria for FEP, further highlight-
ing the potential of an online screening for identifying 
young people that are at-risk for serious mental health 
problems.
However, several issues need to be addressed in future 
studies to improve the clinical utility of an E-mental health 
approach to detect emerging psychosis. Firstly, follow-up 
data on the current sample will provide further informa-
tion on transition rates of CHR participants identified 
through online screening. There is emerging evidence 
that at-risk samples recruited primarily through outreach 
activities may be characterized by lower transition rates 
than in samples referred through clinical pathways.10,39 
Together with the modest specificity of our online screen-
ing, this raises the issue of a substantial number of false 
positive and the risk of conferring stigma in detecting 
CHR participants.40 We would like to note, however, that 
in the course of interviewing a large number of CHR 
participants recruited through our online pathway, we 
rarely encountered concerns about being labeled. This 
anecdotal observation is consistent with data suggesting 
that young people who are deemed to be at potential risk 
for psychosis value the opportunity of talking about their 
experiences rather than express explicit concerns about 
stigma.41
Nonetheless, it is important that future studies investigate 
the possibility of improving sensitivity and specificity of 
online detection of CHR participants through additional 
variables, such as premorbid adjustment, psychosocial 
functioning and neurocognition, that are associated with 
the CHR status and psychosis risk.42,43 This is supported 
by emerging evidence suggests that additional clinical 
and demographic variables increase accuracy of predict-
ing conversion to psychosis in clinically ascertained CHR 
samples.42,43 Such refined online screening could also poten-
tially allow the detection of FEP cases as demonstrated by 
findings from the PQ-16 in our sample that showed that 
the FEP group had significantly elevated scores compared 
to CHR participants. This issue is potentially important as 
current evidence suggests that specialized high-risk clinics 
only identify around 5% of FEP cases.42 Accordingly, devel-
opment of novel tools that allow the identification of both 
FEP cases as well as participants meeting CHR criteria 
would be important for early intervention.
Summary
In summary, our data provide evidence that it is possi-
ble to identify CHR participants through online screen-
ing at the population level. This approach could have 
implications for efforts to identify young people at-risk 
of mental health problems as well as for the identifica-
tion of emerging psychosis. Future studies are required to 
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improve sensitivity and specificity through the addition 
of clinical, demographic, and neurocognitive variables. 
Moreover, it is conceivable that the current framework 
could be extended to secondary mental health settings 
as well as for related disorders that typically emerge dur-
ing the transition from adolescence to adulthood, such 
as affective disorders and borderline personality disorder.
Supplementary Material
Supplementary data are available at Schizophrenia 
Bulletin online.
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Appendix: PCA Questionnaire
Instructions: You are asked to complete a questionnaire which will ask about recent thoughts, feelings, and experiences. 
We are interested in exploring the links between the presence of thoughts and feelings and the potential risk for the 
development of mental health problems.
Please answer the questions honestly based only on how you have been feeling in the last 12 months.
Please note that you should not answer questions based on recent experiences that occurred only while under the influ-
ence of alcohol, drugs, or medications that were not prescribed to you.
If true: how much distress did you experience?
True False None Mild Moderate Severe
1. Do you have sometimes the impression that you cannot 
understand spoken or written words immediately, although 
these words are familiar to you?
2. Have you noticed that you cannot remember familiar words or 
terms so that you have to search for them longer or that you 
have to use other words instead?
3. Does it happen sometimes that too many thoughts race through 
your head without any connection between them?
4. Do you sometimes find it more difficult than in the past to 
direct your attention onto 2 different things, eg, to follow a 
conversation and at the same time to take some notes, to drive a 
car or wash dishes?
5. Does it happen to you that you can only concentrate with 
difficulties on a movie or a book, because nonrelevant thoughts 
distract or bother you, although these topics are actually 
without importance to you?
6. Have you recently experienced that your stream of thoughts is 
getting disrupted, so that your present thought disappears or 
you cannot follow it anymore?
7. Does it happen to you that experiences or conversations go 
through your mind again and again although these are actually 
nonsignificant and you would prefer to occupy yourself  with 
other things?
8. Does it happen to you that you can only hear snatches of 
conversation but you cannot fit them together in a meaningful 
way?
9. Do things sometimes appear to be split up like a photograph 
that’s torn in bits and put together again?
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